Lessons from Timing of Ablation Therapy for Multi-Drug Refractory
Gestational Atrial Tachycardia with Abruptio Placentae
Supraventricular tachycardia (SVT) poses a clinical challenge during
pregnancy, particularly if refractory to antiarrhythmic medications.
Performing catheter ablation during pregnancy necessitates careful risk
benefit analysis for both the mother and fetus, especially with
left-sided ablations that may require post-procedural systemic
anticoagulation. We describe a pregnant woman with refractory atrial
tachycardia (AT) which failed a multi-antiarrhythmic drug regimen and
ultimately developed abruptio placentae, requiring a carefully staged
ablation approach for definitive treatment.